1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. VIRPAX PHARMACEUTICALS INC

Virpax Pharmaceuticals Inc

XNAS: VRPX

Download real time

2.94 0.44 (17.60%)

New 52W Low in past week

1.2M XNAS Volume

High volume+gain today

XNAS 21 Mar, 2025 10:06 AM (EDT)

Watchlist

Portfolio

Share
11S
10W
0O
4T
3.1

Market Cap

Low in industry
-0.3

PE TTM

Negative PE TTM
0

PEG TTM

-38.1

Price to Book

Negative Price to Book
-0.5

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Virpax Pharmaceuticals Inc is on 26 Mar 2025 for the purpose of Virpax Pharmaceuticals Inc Fourth Quarter Earnings Results for 2024 See details


Insider Trading disclosures for Virpax Pharmaceuticals Inc

The latest disclosure was made by Katharyn Field in Virpax Pharmaceuticals Inc where a trade of 2,500 Stock Option (right to buy) done was reported to US exchanges on July 5, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Katharyn Field Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jul 2024 2,500 2,500 - - Stock Option (right to buy)
Jatinder Dhaliwal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jul 2024 2,500 2,500 - - Stock Option (right to buy)
Sheila A. Mathias Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2024 112,000 112,000 - - Stock Option (right to buy)
Michael Dubin F. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2024 25,000 25,000 - - Stock Option (right to buy)
Thani Jambulingam Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2024 25,000 25,000 - - Stock Option (right to buy)
Vinay Shah Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2024 112,000 112,000 - - Stock Option (right to buy)
Floyd Eric Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2024 45,000 45,000 - - Stock Option (right to buy)
Ruskin Barbara Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2024 25,000 25,000 - - Stock Option (right to buy)
Sendrow Jerrold Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2024 25,000 25,000 - - Stock Option (right to buy)
Singh M. Vanila Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2024 25,000 25,000 - - Stock Option (right to buy)
W. Gerald Bruce Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2024 125,000 125,000 - - Stock Option (right to buy)
Vinay Shah Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2023 100,000 100,000 - - Stock Option (right to buy)
Gerald W. Bruce Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2023 100,000 100,000 - - Stock Option (right to buy)
Barbara Ruskin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2023 25,000 25,000 - - Stock Option (right to buy)
Christopher M. Chipman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2023 112,000 112,000 - - Stock Option (right to buy)
Anthony Mack Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2023 125,000 125,000 - - Stock Option (right to buy)
Jeffrey Gudin Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2023 50,000 50,000 - - Stock Option (right to buy)
Thani Jambulingam Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2023 40,000 40,000 - - Stock Option (right to buy)
Jerrold Sendrow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2023 35,000 35,000 - - Stock Option (right to buy)
Eric Floyd Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2023 45,000 45,000 - - Stock Option (right to buy)
Vanila M. Singh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2023 15,000 15,000 - - Stock Option (right to buy)
Michael F. Dubin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2023 20,000 20,000 - - Stock Option (right to buy)
Jerrold Sendrow Director Purchase of securities on an exchange or from another person at price $ 1.29 per share. 24 May 2022 4,500 9,006 - 1.3 5,805 Common Stock, $0.00001 par value
Eric Floyd Director Purchase of securities on an exchange or from another person at price $ 1.36 per share. 18 May 2022 4,479 8,018 - 1.4 6,107 Common Stock, $0.00001 par value
Anthony Mack Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.34 per share. 18 May 2022 75,750 252,562 - 1.3 101,505 Common Stock, $0.00001 par value
Gerald W. Bruce Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Apr 2022 60,000 60,000 - - Stock Option (right to buy)
Christopher M. Chipman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 60,676 60,676 - - Stock Option (right to buy)
Anthony Mack Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 60,676 60,676 - - Stock Option (right to buy)
Jeffrey Gudin Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 60,676 60,676 - - Stock Option (right to buy)
Thani Jambulingam Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 14,113 14,113 - - Stock Option (right to buy)
Jerrold Sendrow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 12,091 12,091 - - Stock Option (right to buy)
Eric Floyd Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 15,124 15,124 - - Stock Option (right to buy)
Vanila M. Singh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 12,091 12,091 - - Stock Option (right to buy)
Gary S. Jacob Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 12,091 12,091 - - Stock Option (right to buy)
Michael F. Dubin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 12,091 12,091 - - Stock Option (right to buy)
Jerrold Sendrow Director Purchase of securities on an exchange or from another person at price $ 3.93 per share. 22 Nov 2021 3,900 4,506 - 3.9 15,308 Common Stock, $0.00001 par value
Anthony Mack Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 3.99 per share. 18 Nov 2021 25,125 176,812 - 4.0 100,249 Common Stock, $0.00001 par value
Michael F. Dubin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jul 2021 20,225 20,225 - - Stock Option (right to buy)
Thani Jambulingam Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2021 10,205 10,205 - - Stock Option (right to buy)
Jerrold Sendrow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2021 10,205 10,205 - - Stock Option (right to buy)
Eric Floyd Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2021 11,216 11,216 - - Stock Option (right to buy)
Jeffrey Gudin Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2021 50,000 50,000 - - Stock Option (right to buy)
Anthony Mack Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2021 50,000 50,000 - - Stock Option (right to buy)
Vanila M. Singh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2021 8,183 8,183 - - Stock Option (right to buy)
Christopher M. Chipman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2021 25,000 25,000 - - Stock Option (right to buy)
Gary S. Jacob Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2021 13,183 13,183 - - Stock Option (right to buy)
Gary S. Jacob Director Purchase of securities on an exchange or from another person at price $ 6.79 per share. 17 Feb 2021 3,500 3,500 - 6.8 23,762 Common Stock, $0.00001 par value
Thani Jambulingam Director Purchase of securities on an exchange or from another person at price $ 7.16 per share. 17 Feb 2021 100 100 - 7.2 716 Common Stock, $0.00001 par value
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters